Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 62 entries
Sorted by: Best Match Show Resources per page
[Epidemiology, prevention and early detection of cervical cancer].

Der Onkologe : Organ der Deutschen Krebsgesellschaft e.V

Wentzensen N.
PMID: 28265177
Onkologe (Berl). 2016 Oct;22(10):725-736. doi: 10.1007/s00761-016-0092-7. Epub 2016 Aug 04.

BACKGROUND: Persistent infections with human papillomaviruses are a necessary cause of cervical carcinomas. The development of HPV-based prevention tools, HPV vaccination and HPV testing, is leading to major changes in cervical cancer prevention programs worldwide. A decade after introduction...

Cite
Wentzensen N. Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms. [Epidemiology, prevention and early detection of cervical cancer]. Onkologe (Berl). 2016;22(10):725-736doi: 10.1007/s00761-016-0092-7.
Wentzensen, N. (2016). Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms. [Epidemiology, prevention and early detection of cervical cancer]. Der Onkologe : Organ der Deutschen Krebsgesellschaft e.V, 22(10), 725-736. https://doi.org/10.1007/s00761-016-0092-7
Wentzensen, Nicolas. "Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms." [Epidemiology, prevention and early detection of cervical cancer]. Der Onkologe : Organ der Deutschen Krebsgesellschaft e.V vol. 22,10 (2016): 725-736. doi: https://doi.org/10.1007/s00761-016-0092-7
Wentzensen N. Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms. [Epidemiology, prevention and early detection of cervical cancer]. Onkologe (Berl). 2016 Oct;22(10):725-736. doi: 10.1007/s00761-016-0092-7. Epub 2016 Aug 04. Scottish Gaelic. PMID: 28265177; PMCID: PMC5336232.
Copy Download .nbib Format: NLM
Non-unions treated with bone morphogenic protein 7: introducing the quantitative measurement of human serum cytokine levels as promising tool in evaluation of adjunct non-union therapy.

Journal of inflammation (London, England)

Moghaddam A, Breier L, Haubruck P, Bender D, Biglari B, Wentzensen A, Zimmermann G.
PMID: 26807043
J Inflamm (Lond). 2016 Jan 22;13:3. doi: 10.1186/s12950-016-0111-x. eCollection 2016.

BACKGROUND: In this study we sought to determine if application of bone morphogenic protein 7 (BMP-7) promotes physiological bone healing of non-unions and to investigate if serum cytokine analysis may serve as a promising tool in the analysis of...

Cite
Moghaddam A, Breier L, Haubruck P, et al. Non-unions treated with bone morphogenic protein 7: introducing the quantitative measurement of human serum cytokine levels as promising tool in evaluation of adjunct non-union therapy. J Inflamm (Lond). 2016;13:3doi: 10.1186/s12950-016-0111-x.
Moghaddam, A., Breier, L., Haubruck, P., Bender, D., Biglari, B., Wentzensen, A., & Zimmermann, G. (2016). Non-unions treated with bone morphogenic protein 7: introducing the quantitative measurement of human serum cytokine levels as promising tool in evaluation of adjunct non-union therapy. Journal of inflammation (London, England), 133. https://doi.org/10.1186/s12950-016-0111-x
Moghaddam, Arash, et al. "Non-unions treated with bone morphogenic protein 7: introducing the quantitative measurement of human serum cytokine levels as promising tool in evaluation of adjunct non-union therapy." Journal of inflammation (London, England) vol. 13 (2016): 3. doi: https://doi.org/10.1186/s12950-016-0111-x
Moghaddam A, Breier L, Haubruck P, Bender D, Biglari B, Wentzensen A, Zimmermann G. Non-unions treated with bone morphogenic protein 7: introducing the quantitative measurement of human serum cytokine levels as promising tool in evaluation of adjunct non-union therapy. J Inflamm (Lond). 2016 Jan 22;13:3. doi: 10.1186/s12950-016-0111-x. eCollection 2016. PMID: 26807043; PMCID: PMC4724145.
Copy Download .nbib Format: NLM
Rupture of the pubic symphysis: Diagnosis, treatment and clinical outcome.

Annals of Saudi medicine

Weber K, Vock B, Muller W, Wentzensen A.
PMID: 17277479
Ann Saudi Med. 1999 Nov-Dec;19(6):544-6. doi: 10.5144/0256-4947.1999.544.

No abstract available.

Cite
Weber K, Vock B, Muller W, et al. Rupture of the pubic symphysis: Diagnosis, treatment and clinical outcome. Ann Saudi Med. 1999;19(6):544-6doi: 10.5144/0256-4947.1999.544.
Weber, K., Vock, B., Muller, W., & Wentzensen, A. (1999). Rupture of the pubic symphysis: Diagnosis, treatment and clinical outcome. Annals of Saudi medicine, 19(6), 544-6. https://doi.org/10.5144/0256-4947.1999.544
Weber, K, et al. "Rupture of the pubic symphysis: Diagnosis, treatment and clinical outcome." Annals of Saudi medicine vol. 19,6 (1999): 544-6. doi: https://doi.org/10.5144/0256-4947.1999.544
Weber K, Vock B, Muller W, Wentzensen A. Rupture of the pubic symphysis: Diagnosis, treatment and clinical outcome. Ann Saudi Med. 1999 Nov-Dec;19(6):544-6. doi: 10.5144/0256-4947.1999.544. PMID: 17277479.
Copy Download .nbib Format: NLM
Early detection of cervical carcinomas: finding an overall approach.

Deutsches Arzteblatt international

Wentzensen N, Klug SJ.
PMID: 19471627
Dtsch Arztebl Int. 2008 Sep;105(37):617-22. doi: 10.3238/arztebl.2008.0617. Epub 2008 Sep 12.

BACKGROUND: Infection with human papillomavirus (HPV) is a necessary, but not sufficient condition for the emergence of cervical cancer. Cervical cancer develops over several years through a series of precursor lesions that can be detected by cytological screening. The...

Cite
Wentzensen N, Klug SJ. Early detection of cervical carcinomas: finding an overall approach. Dtsch Arztebl Int. 2008;105(37):617-22doi: 10.3238/arztebl.2008.0617.
Wentzensen, N., & Klug, S. J. (2008). Early detection of cervical carcinomas: finding an overall approach. Deutsches Arzteblatt international, 105(37), 617-22. https://doi.org/10.3238/arztebl.2008.0617
Wentzensen, Nicolas, and Klug, Stefanie J. "Early detection of cervical carcinomas: finding an overall approach." Deutsches Arzteblatt international vol. 105,37 (2008): 617-22. doi: https://doi.org/10.3238/arztebl.2008.0617
Wentzensen N, Klug SJ. Early detection of cervical carcinomas: finding an overall approach. Dtsch Arztebl Int. 2008 Sep;105(37):617-22. doi: 10.3238/arztebl.2008.0617. Epub 2008 Sep 12. PMID: 19471627; PMCID: PMC2680567.
Copy Download .nbib Format: NLM
The treatment of infected tibial pilon fractures.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Heppert V, Hochstein P, Aymar M, Wentzensen A.
PMID: 24193340
Eur J Orthop Surg Traumatol. 1995 Dec;5(2):161-3. doi: 10.1007/BF02716264.

A total of 33 patients with infection after pilon fracture were retrospectively reviewed from 1988 to 1992. Twenty patients were transfered from peripheral hospitals with active osteitis, 13 patients were treated primarily in our hospital. Factors inducing infection in...

Cite
Heppert V, Hochstein P, Aymar M, et al. The treatment of infected tibial pilon fractures. Eur J Orthop Surg Traumatol. 1995;5(2):161-3doi: 10.1007/BF02716264.
Heppert, V., Hochstein, P., Aymar, M., & Wentzensen, A. (1995). The treatment of infected tibial pilon fractures. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 5(2), 161-3. https://doi.org/10.1007/BF02716264
Heppert, V, et al. "The treatment of infected tibial pilon fractures." European journal of orthopaedic surgery & traumatology : orthopedie traumatologie vol. 5,2 (1995): 161-3. doi: https://doi.org/10.1007/BF02716264
Heppert V, Hochstein P, Aymar M, Wentzensen A. The treatment of infected tibial pilon fractures. Eur J Orthop Surg Traumatol. 1995 Dec;5(2):161-3. doi: 10.1007/BF02716264. PMID: 24193340.
Copy Download .nbib Format: NLM
Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.

Nature communications

Blok LS, Rousseau J, Twist J, Ehresmann S, Takaku M, Venselaar H, Rodan LH, Nowak CB, Douglas J, Swoboda KJ, Steeves MA, Sahai I, Stumpel CTRM, Stegmann APA, Wheeler P, Willing M, Fiala E, Kochhar A, Gibson WT, Cohen ASA, Agbahovbe R, Innes AM, Au PYB, Rankin J, Anderson IJ, Skinner SA, Louie RJ, Warren HE, Afenjar A, Keren B, Nava C, Buratti J, Isapof A, Rodriguez D, Lewandowski R, Propst J, van Essen T, Choi M, Lee S, Chae JH, Price S, Schnur RE, Douglas G, Wentzensen IM, Zweier C, Reis A, Bialer MG, Moore C, Koopmans M, Brilstra EH, Monroe GR, van Gassen KLI, van Binsbergen E, Newbury-Ecob R, Bownass L, Bader I, Mayr JA, Wortmann SB, Jakielski KJ, Strand EA, Kloth K, Bierhals T, Roberts JD, Petrovich RM, Machida S, Kurumizaka H, Lelieveld S, Pfundt R, Jansen S, Deriziotis P, Faivre L, Thevenon J, Assoum M, Shriberg L, Kleefstra T, Brunner HG, Wade PA, Fisher SE, Campeau PM.
PMID: 30770872
Nat Commun. 2019 Feb 15;10(1):883. doi: 10.1038/s41467-019-08800-2.

The original version of this Article contained an error in the spelling of the author Laurence Faivre, which was incorrectly given as Laurence Faive. This has now been corrected in both the PDF and HTML versions of the Article.

Cite
Blok LS, Rousseau J, Twist J, et al. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun. 2019;10(1):883doi: 10.1038/s41467-019-08800-2.
Blok, L. S., Rousseau, J., Twist, J., Ehresmann, S., Takaku, M., Venselaar, H., Rodan, L. H., Nowak, C. B., Douglas, J., Swoboda, K. J., Steeves, M. A., Sahai, I., Stumpel, C. T. R. M., Stegmann, A. P. A., Wheeler, P., Willing, M., Fiala, E., Kochhar, A., Gibson, W. T., Cohen, A. S. A., Agbahovbe, R., Innes, A. M., Au, P. Y. B., Rankin, J., Anderson, I. J., Skinner, S. A., Louie, R. J., Warren, H. E., Afenjar, A., Keren, B., Nava, C., Buratti, J., Isapof, A., Rodriguez, D., Lewandowski, R., Propst, J., van Essen, T., Choi, M., Lee, S., Chae, J. H., Price, S., Schnur, R. E., Douglas, G., Wentzensen, I. M., Zweier, C., Reis, A., Bialer, M. G., Moore, C., Koopmans, M., Brilstra, E. H., Monroe, G. R., van Gassen, K. L. I., van Binsbergen, E., Newbury-Ecob, R., Bownass, L., Bader, I., Mayr, J. A., Wortmann, S. B., Jakielski, K. J., Strand, E. A., Kloth, K., Bierhals, T., Roberts, J. D., Petrovich, R. M., Machida, S., Kurumizaka, H., Lelieveld, S., Pfundt, R., Jansen, S., Deriziotis, P., Faivre, L., Thevenon, J., Assoum, M., Shriberg, L., Kleefstra, T., Brunner, H. G., Wade, P. A., Fisher, S. E., & Campeau, P. M. (2019). Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nature communications, 10(1), 883. https://doi.org/10.1038/s41467-019-08800-2
Blok, Lot Snijders, et al. "Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language." Nature communications vol. 10,1 (2019): 883. doi: https://doi.org/10.1038/s41467-019-08800-2
Blok LS, Rousseau J, Twist J, Ehresmann S, Takaku M, Venselaar H, Rodan LH, Nowak CB, Douglas J, Swoboda KJ, Steeves MA, Sahai I, Stumpel CTRM, Stegmann APA, Wheeler P, Willing M, Fiala E, Kochhar A, Gibson WT, Cohen ASA, Agbahovbe R, Innes AM, Au PYB, Rankin J, Anderson IJ, Skinner SA, Louie RJ, Warren HE, Afenjar A, Keren B, Nava C, Buratti J, Isapof A, Rodriguez D, Lewandowski R, Propst J, van Essen T, Choi M, Lee S, Chae JH, Price S, Schnur RE, Douglas G, Wentzensen IM, Zweier C, Reis A, Bialer MG, Moore C, Koopmans M, Brilstra EH, Monroe GR, van Gassen KLI, van Binsbergen E, Newbury-Ecob R, Bownass L, Bader I, Mayr JA, Wortmann SB, Jakielski KJ, Strand EA, Kloth K, Bierhals T, Roberts JD, Petrovich RM, Machida S, Kurumizaka H, Lelieveld S, Pfundt R, Jansen S, Deriziotis P, Faivre L, Thevenon J, Assoum M, Shriberg L, Kleefstra T, Brunner HG, Wade PA, Fisher SE, Campeau PM. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun. 2019 Feb 15;10(1):883. doi: 10.1038/s41467-019-08800-2. PMID: 30770872; PMCID: PMC6377600.
Copy Download .nbib Format: NLM
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.

Oncotarget

MacKay HJ, Levine DA, Bae-Jump VL, Bell DW, McAlpine JN, Santin A, Fleming GF, Mutch DG, Nephew KP, Wentzensen N, Goodfellow PJ, Dorigo O, Nijman HW, Broaddus R, Kohn EC.
PMID: 29137450
Oncotarget. 2017 Aug 03;8(48):84579-84594. doi: 10.18632/oncotarget.19961. eCollection 2017 Oct 13.

The incidence and mortality rates from endometrial cancer are increasing. There have been no new drugs approved for the treatment of endometrial cancer in decades. The National Cancer Institute, Gynecologic Cancer Steering Committee identified the integration of molecular and/or...

Cite
MacKay HJ, Levine DA, Bae-Jump VL, et al. Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget. 2017;8(48):84579-84594doi: 10.18632/oncotarget.19961.
MacKay, H. J., Levine, D. A., Bae-Jump, V. L., Bell, D. W., McAlpine, J. N., Santin, A., Fleming, G. F., Mutch, D. G., Nephew, K. P., Wentzensen, N., Goodfellow, P. J., Dorigo, O., Nijman, H. W., Broaddus, R., & Kohn, E. C. (2017). Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget, 8(48), 84579-84594. https://doi.org/10.18632/oncotarget.19961
MacKay, Helen J, et al. "Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials." Oncotarget vol. 8,48 (2017): 84579-84594. doi: https://doi.org/10.18632/oncotarget.19961
MacKay HJ, Levine DA, Bae-Jump VL, Bell DW, McAlpine JN, Santin A, Fleming GF, Mutch DG, Nephew KP, Wentzensen N, Goodfellow PJ, Dorigo O, Nijman HW, Broaddus R, Kohn EC. Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget. 2017 Aug 03;8(48):84579-84594. doi: 10.18632/oncotarget.19961. eCollection 2017 Oct 13. PMID: 29137450; PMCID: PMC5663622.
Copy Download .nbib Format: NLM
Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.

Nature communications

Snijders Blok L, Rousseau J, Twist J, Ehresmann S, Takaku M, Venselaar H, Rodan LH, Nowak CB, Douglas J, Swoboda KJ, Steeves MA, Sahai I, Stumpel CTRM, Stegmann APA, Wheeler P, Willing M, Fiala E, Kochhar A, Gibson WT, Cohen ASA, Agbahovbe R, Innes AM, Au PYB, Rankin J, Anderson IJ, Skinner SA, Louie RJ, Warren HE, Afenjar A, Keren B, Nava C, Buratti J, Isapof A, Rodriguez D, Lewandowski R, Propst J, van Essen T, Choi M, Lee S, Chae JH, Price S, Schnur RE, Douglas G, Wentzensen IM, Zweier C, Reis A, Bialer MG, Moore C, Koopmans M, Brilstra EH, Monroe GR, van Gassen KLI, van Binsbergen E, Newbury-Ecob R, Bownass L, Bader I, Mayr JA, Wortmann SB, Jakielski KJ, Strand EA, Kloth K, Bierhals T, Roberts JD, Petrovich RM, Machida S, Kurumizaka H, Lelieveld S, Pfundt R, Jansen S, Deriziotis P, Faivre L, Thevenon J, Assoum M, Shriberg L, Kleefstra T, Brunner HG, Wade PA, Fisher SE, Campeau PM.
PMID: 31048695
Nat Commun. 2019 May 02;10(1):2079. doi: 10.1038/s41467-019-10161-9.

The HTML and PDF versions of this Article were updated after publication to remove images of one individual from Figure 1.

Cite
Snijders Blok L, Rousseau J, Twist J, et al. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun. 2019;10(1):2079doi: 10.1038/s41467-019-10161-9.
Snijders Blok, L., Rousseau, J., Twist, J., Ehresmann, S., Takaku, M., Venselaar, H., Rodan, L. H., Nowak, C. B., Douglas, J., Swoboda, K. J., Steeves, M. A., Sahai, I., Stumpel, C. T. R. M., Stegmann, A. P. A., Wheeler, P., Willing, M., Fiala, E., Kochhar, A., Gibson, W. T., Cohen, A. S. A., Agbahovbe, R., Innes, A. M., Au, P. Y. B., Rankin, J., Anderson, I. J., Skinner, S. A., Louie, R. J., Warren, H. E., Afenjar, A., Keren, B., Nava, C., Buratti, J., Isapof, A., Rodriguez, D., Lewandowski, R., Propst, J., van Essen, T., Choi, M., Lee, S., Chae, J. H., Price, S., Schnur, R. E., Douglas, G., Wentzensen, I. M., Zweier, C., Reis, A., Bialer, M. G., Moore, C., Koopmans, M., Brilstra, E. H., Monroe, G. R., van Gassen, K. L. I., van Binsbergen, E., Newbury-Ecob, R., Bownass, L., Bader, I., Mayr, J. A., Wortmann, S. B., Jakielski, K. J., Strand, E. A., Kloth, K., Bierhals, T., Roberts, J. D., Petrovich, R. M., Machida, S., Kurumizaka, H., Lelieveld, S., Pfundt, R., Jansen, S., Deriziotis, P., Faivre, L., Thevenon, J., Assoum, M., Shriberg, L., Kleefstra, T., Brunner, H. G., Wade, P. A., Fisher, S. E., & Campeau, P. M. (2019). Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nature communications, 10(1), 2079. https://doi.org/10.1038/s41467-019-10161-9
Snijders Blok, Lot, et al. "Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language." Nature communications vol. 10,1 (2019): 2079. doi: https://doi.org/10.1038/s41467-019-10161-9
Snijders Blok L, Rousseau J, Twist J, Ehresmann S, Takaku M, Venselaar H, Rodan LH, Nowak CB, Douglas J, Swoboda KJ, Steeves MA, Sahai I, Stumpel CTRM, Stegmann APA, Wheeler P, Willing M, Fiala E, Kochhar A, Gibson WT, Cohen ASA, Agbahovbe R, Innes AM, Au PYB, Rankin J, Anderson IJ, Skinner SA, Louie RJ, Warren HE, Afenjar A, Keren B, Nava C, Buratti J, Isapof A, Rodriguez D, Lewandowski R, Propst J, van Essen T, Choi M, Lee S, Chae JH, Price S, Schnur RE, Douglas G, Wentzensen IM, Zweier C, Reis A, Bialer MG, Moore C, Koopmans M, Brilstra EH, Monroe GR, van Gassen KLI, van Binsbergen E, Newbury-Ecob R, Bownass L, Bader I, Mayr JA, Wortmann SB, Jakielski KJ, Strand EA, Kloth K, Bierhals T, Roberts JD, Petrovich RM, Machida S, Kurumizaka H, Lelieveld S, Pfundt R, Jansen S, Deriziotis P, Faivre L, Thevenon J, Assoum M, Shriberg L, Kleefstra T, Brunner HG, Wade PA, Fisher SE, Campeau PM. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun. 2019 May 02;10(1):2079. doi: 10.1038/s41467-019-10161-9. PMID: 31048695; PMCID: PMC6497626.
Copy Download .nbib Format: NLM
CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum.

Clinical genetics

Palmer EE, Whitton C, Hashem MO, Clark RD, Ramanathan S, Starr LJ, Velasco D, De Dios JK, Singh E, Cormier-Daire V, Chopra M, Rodan LH, Nellaker C, Lakhani S, Mallack EJ, Panzer K, Sidhu A, Wentzensen IM, Lacombe D, Michaud V, Alkuraya FS.
PMID: 34212383
Clin Genet. 2021 Oct;100(4):468-477. doi: 10.1111/cge.14022. Epub 2021 Jul 13.

We describe the clinical features of nine unrelated individuals with rare de novo missense or in-frame deletions/duplications within the "HX motif" of exon 7 of ATN1. We previously proposed that individuals with such variants should be considered as being...

Cite
Palmer EE, Whitton C, Hashem MO, et al. CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum. Clin Genet. 2021;100(4):468-477doi: 10.1111/cge.14022.
Palmer, E. E., Whitton, C., Hashem, M. O., Clark, R. D., Ramanathan, S., Starr, L. J., Velasco, D., De Dios, J. K., Singh, E., Cormier-Daire, V., Chopra, M., Rodan, L. H., Nellaker, C., Lakhani, S., Mallack, E. J., Panzer, K., Sidhu, A., Wentzensen, I. M., Lacombe, D., Michaud, V., & Alkuraya, F. S. (2021). CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum. Clinical genetics, 100(4), 468-477. https://doi.org/10.1111/cge.14022
Palmer, Elizabeth E, et al. "CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum." Clinical genetics vol. 100,4 (2021): 468-477. doi: https://doi.org/10.1111/cge.14022
Palmer EE, Whitton C, Hashem MO, Clark RD, Ramanathan S, Starr LJ, Velasco D, De Dios JK, Singh E, Cormier-Daire V, Chopra M, Rodan LH, Nellaker C, Lakhani S, Mallack EJ, Panzer K, Sidhu A, Wentzensen IM, Lacombe D, Michaud V, Alkuraya FS. CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum. Clin Genet. 2021 Oct;100(4):468-477. doi: 10.1111/cge.14022. Epub 2021 Jul 13. PMID: 34212383.
Copy Download .nbib Format: NLM
Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Raine-Bennett T, Gage JC, Poitras N, Chandra M, Varnado N, Befano B, Schiffman M, Lorey T, Wentzensen N.
PMID: 34768232
J Clin Virol. 2021 Dec;145:105014. doi: 10.1016/j.jcv.2021.105014. Epub 2021 Nov 03.

INTRODUCTION: Biomarkers of Human Papillomavirus (HPV) cervical carcinogenesis are critical to address questions of how to triage and manage women who screen positive for high-risk HPV (HrHPV) and identify those at highest cancer risk.METHODS: We describe the development of...

Cite
Raine-Bennett T, Gage JC, Poitras N, et al. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). J Clin Virol. 2021;145:105014doi: 10.1016/j.jcv.2021.105014.
Raine-Bennett, T., Gage, J. C., Poitras, N., Chandra, M., Varnado, N., Befano, B., Schiffman, M., Lorey, T., & Wentzensen, N. (2021). Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 145105014. https://doi.org/10.1016/j.jcv.2021.105014
Raine-Bennett, Tina, et al. "Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS)." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 145 (2021): 105014. doi: https://doi.org/10.1016/j.jcv.2021.105014
Raine-Bennett T, Gage JC, Poitras N, Chandra M, Varnado N, Befano B, Schiffman M, Lorey T, Wentzensen N. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). J Clin Virol. 2021 Dec;145:105014. doi: 10.1016/j.jcv.2021.105014. Epub 2021 Nov 03. PMID: 34768232.
Copy Download .nbib Format: NLM
Response to Pretorius and Belinson.

Journal of the National Cancer Institute

Schiffman M, Hu L, Antani S, Wentzensen N.
PMID: 31187134
J Natl Cancer Inst. 2020 Jan 01;112(1):115-116. doi: 10.1093/jnci/djz119.

No abstract available.

Cite
Schiffman M, Hu L, Antani S, et al. Response to Pretorius and Belinson. J Natl Cancer Inst. 2020;112(1):115-116doi: 10.1093/jnci/djz119.
Schiffman, M., Hu, L., Antani, S., & Wentzensen, N. (2020). Response to Pretorius and Belinson. Journal of the National Cancer Institute, 112(1), 115-116. https://doi.org/10.1093/jnci/djz119
Schiffman, Mark, et al. "Response to Pretorius and Belinson." Journal of the National Cancer Institute vol. 112,1 (2020): 115-116. doi: https://doi.org/10.1093/jnci/djz119
Schiffman M, Hu L, Antani S, Wentzensen N. Response to Pretorius and Belinson. J Natl Cancer Inst. 2020 Jan 01;112(1):115-116. doi: 10.1093/jnci/djz119. PMID: 31187134; PMCID: PMC7489090.
Copy Download .nbib Format: NLM
Expanding the Phenotype of .

Molecular syndromology

Schmidt L, Wain KE, Hajek C, Estrada-Veras JI, Guillen Sacoto MJ, Wentzensen IM, Malhotra A, Clause A, Perry D, Moreno-De-Luca A, Bell M.
PMID: 33776625
Mol Syndromol. 2021 Mar;12(1):33-40. doi: 10.1159/000512160. Epub 2020 Dec 09.

Tubulinopathies are a group of conditions caused by variants in 6 tubulin genes that present with a spectrum of brain malformations. One of these conditions is

Cite
Schmidt L, Wain KE, Hajek C, et al. Expanding the Phenotype of . Mol Syndromol. 2020;12(1):33-40doi: 10.1159/000512160.
Schmidt, L., Wain, K. E., Hajek, C., Estrada-Veras, J. I., Guillen Sacoto, M. J., Wentzensen, I. M., Malhotra, A., Clause, A., Perry, D., Moreno-De-Luca, A., & Bell, M. (2021). Expanding the Phenotype of . Molecular syndromology, 12(1), 33-40. https://doi.org/10.1159/000512160
Schmidt, Lindsey, et al. "Expanding the Phenotype of ." Molecular syndromology vol. 12,1 (2021): 33-40. doi: https://doi.org/10.1159/000512160
Schmidt L, Wain KE, Hajek C, Estrada-Veras JI, Guillen Sacoto MJ, Wentzensen IM, Malhotra A, Clause A, Perry D, Moreno-De-Luca A, Bell M. Expanding the Phenotype of . Mol Syndromol. 2021 Mar;12(1):33-40. doi: 10.1159/000512160. Epub 2020 Dec 09. PMID: 33776625; PMCID: PMC7983673.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 62 entries